Delays in Vitiligo Treatments: What COVID Lock Downs Revealed

While the COVID-related lockdowns forced many inside, it also meant that a strong majority of vitiligo patients had to pause their treatments, thus resulting in regression of their condition. A new study led by Xinya Xu, MD, Ph.D., of Fudan University in China, discovered that patients who delayed treatment for multiple months saw a regression in treatment progress and a progression in symptoms. The study also concluded that new protocols need to be written to include future pandemic measures to avoid delays or disruptions in a patient’s treatment schedule.

“Our findings revealed the independent adverse impact of treatment delays on the progression and recurrence of vitiligo and protective effect of maintenance therapy (>2 years) against recurrence, indicating the significance of continuous treatment for halting progression and long-term maintenance therapy for preventing recurrence,” Xu and colleagues wrote.

“Therefore, teledermatology and home phototherapy would be recommended, especially for the patients with risk factors.”

[i] Xinya Xu, MD, PhD. Impact of treatment delays on vitiligo during the COVID-19 Pandemic: A Retrospective Study

Winter Weather And Eczema

Eczema or atopic dermatitis is an allergic disease believed to be hereditary and often runs in families whose members also have asthma. An itchy rash
Read More